curriculum vitae - Scuola Superiore Sant`Anna
Transcript
curriculum vitae - Scuola Superiore Sant`Anna
LEOPOLDO TRIESTE Contact Information Personal data Last Update: July 18, 2016 Business Addresses Residence Scuola Superiore Sant’Anna 10, p.zza Bastreri Institute of Management, Porto Venere, SP, 19025 33, p.zza Martiri della Libertà Pisa, PI, 56127 19, via la Maddalena, +39 050 883816 Pisa, PI, 56125 +39 338 8477889 [email protected] http://www.santannapisa.it/it/personale/leopoldo-trieste Date of birth: March 29, 1980 Nationality: Italian Research Interests Management, health economics, HTA, innovation diffusion, decision models and simulation in health economic evaluation. Education Specialization courses DES Simulation for Economic Analyses I-II Milan (IT), ISPOR. Advisors: J. Jaime Caro, Jörgen Möller Nov. 9, 2015 Management of No-profit Clinical Trials Genoa (IT), CISEF, Gaslini Institute. Jan. 29, 2015 Bayesian Analysis and application in Health Economics Nov 9, 2014 Amsterdam (NL), ISPOR. Advisors: Christopher S. Hollenbeak, Keith R. Abrams. Economic Evaluation of Health Care Programmes July 17-19, 2014 Turin (IT), SIFO. Advisors: Michael F. Drummond, Mark Sculpher, and Andrea Manca. Clinical trial in Pediatrics and for Rare Diseases Dec. 18-20, 2013 Genoa (IT), CISEF, Gaslini Institute. Advisors: Ornella della Casa Alberighi, Romano Arcieri. Philosophy of technology Milan, Bocconi University. Advisor: Emanuele Severino Nov. 2001 - June 2002 University education Ph.D. Management, Competitiveness and Development 2007 - 2010 Scuola Superiore Sant’Anna, Pisa (IT) Topic: Economic implications of market deregulation. The Italian OtC retail market Advisors: Giuseppe Turchetti and Riccardo Varaldo. Final score: 100/100 magna cum laude. M.Sc. Management of Innovation Scuola Superiore Sant’Anna, Pisa (IT) Topic: Scenario analysis for future business. Advisor: Andrea Piccaluga. 2004 - 2005 B.A. Economics, Statistics and Social Science Bocconi University, Milan (IT) Thesis: Bayesian and non Bayesian updating in decision making Advisor: Aldo Montesano, Fabio Maccheroni 1999 - 2004 1 of 8 Current Position Post Doc researcher Institute of Management, Scuola Superiore Sant’Anna Researcher IN-SAT Lab, Scuola Superiore Sant’Anna Advisor: Riccardo Varaldo Researcher CRF-BIT, FIAT Research Center Advisor: Paolo Dindo Partecipation in National and International projects 2010 to present 2006 - 2010 2005 RACE 2016-2018 Regional project (Tuscany) on the development of an economic decision support system for the real time assessment and simulation of the cost-effectiveness of alternative treatments and patients’ follow-up. Implementation of Chronic Care Model 2014-2016 Implementation of Chronic Care Model using Tele-care and Home care, in patients with multiple comorbidities: evaluation of the cost-effectiveness and quality of life (Funded by Italian Ministry of Health; code RF-2011-02350801) - 2014-2017. The principal aim is to develop Health Care management models (i.e. CCM) supported by the use of low cost Tele-care tools (telemonitoring with registration of clinical data on the GPs Electronic Health Records). The second aim is to assess the impact of Tele-care on quality of care, health related QoL, costs and equity of access to healthcare services on community living disabled elderly people with chronic health conditions. Robot-Era 2012-2015 RobotEra Project (FP7-288899). Project title: Implementation and integration of advanced Robotic systems and intelligent Environments in real scenarios for Ageing population: specific attention is devoted to the evaluation and the assessment (effectiveness, cost-effectiveness and quality of life) of novel technologies developed in the project, in a Health Technology Assessment (HTA) perspective. Impact 2012-2014 HTA and analysis of the clinical decision making changes of portable ultrasounds for general practitioners. Scuola Superiore Sant’Anna, Pisa University, Esaote s.p.a. Radicea 2011-2015 Radices Project, No. 40-41800-98-007 ERA-NET PrioMedchild: New drugs for rare diseases: cost-effectiveness modellng in cryopyrin associated periodic syndromes (CAPS). Project sponsored by AIFA - Agenzia italiana per il Farmaco (I), and ANR - Agency Nationale de la Recerche (F). Past projects - Analisi di impatto e strategie di valorizzazione 2008-2010 dell’insediamento Alenia Composite, Scuola Superiore Sant’Anna, Finmeccanica, Alenia Aeronautica, Boeing. - L’erogazione in farmacia di servizi 2008 integrati con il SSR. Analisi dell?impatto economico - organizzativo. Scuola Superiore Sant’Anna, U.R.TO.FAR. 2 of 8 - Gli Scenari di sviluppo della G.D.O. nel mercato O.T.C. 2006 Scuola Superiore Sant’Anna, Pisa, Parma University, Boeringher-Ingelheim; Institutional positions Vice President of the ISPOR student chapter Treasurer of the SPOR student chapter at Scuola Sant’Anna Representative of the IDM Post-Doc Researchers Instutue of Management council, Scuola Superiore Sant’Anna. from 2015 2013 - 2015 from 2014 Representative of the PhD-Students 2008-2009 in Economics and Management, Council of the Sant’Anna School of Advanced Study, Social Science Class. Teaching Experience Challenges and Constraints in Producing, July 14 2016 Assessing and Transferring the Value of Assistive Robotics 1st International Summer School in Regulation of Robotics in Europe: Legal, Ethical and Economic Implications. Scuola Superiore Sant’Anna Valutazione economiche: concetti e modelli per i programmi di telemedicina Sapienza University of Rome. May 2016 Management of Innovation from 2014 Module Coordinator (PhD. course, in English), Pisa University Faculty of Information Engineering and TeCiP, Scuola Superiore Sant’Anna Models and methods for Health Economic evaluation Pisa University, Medicine and Biomedical Engineering Faculties Economic Evaluation of Health Care Programmes Master: ”Smart Solutions - Smart Communities (SSSC)”. Scuola Superiore Sant’Anna Theory of clinical decision making Pisa University, Faculty of Biomedical Engineering from 2014 November 2014 from 2012 The Monti decree: future scenarios: bad and good strategies Spring 2009 SIAF International School for Advanced Education New governance and the pharmacy network SIAF International School for Advanced Education Spring 2008 The economic impacts of new services in pharmacy Nov. 2007 - April 2008 SIAF International School for Advanced Education Marketing, market and business; Firm strategies Fabrica 136-Pon-Tech Refereed Journal Publications Feb.-March 2007 1. Tagliente, I., Solvoll, T., Trieste, L., De Cecco, C., Murgia, F., Bella, S. Which indicators for measuring the daily physical activity? An overview on the challenges and technology limits for telehealth applications. Journal of Technology and 3 of 8 Health Care 2016: 1: 1-8. 2. Tagliente, I., Trieste, L., Solvoll, T., Murgia, F., Bella, S. Telemonitoring in Cystic Fibrosis: A 4-year Assessment and Simulation for the Next 6 Years Interact J Med Res 2016; 5(2): e11. 3. Salvini, P., Bertolini, A., Pagliai, T., Morachioli, A., Acerbi, G., Trieste, L., Cavallo, F., Turchetti, G., Dario, P. On robots and insurance. Inter. J. of Social Robotics 2016. 4. Triulzi, I., Trieste, L., Belli, C., Pani, M. Turchetti, G. 2016. Development of an Objective Feedback score for the evaluation of drug and medical device manufacturers/distributors as an additional parameter to be considered in public procurement. Eur J Hosp Pharm 2016;23(Suppl 1): A115. 5. Trieste, L., Della Casa Alberighi O, Turchetti G, Pierotti F, Accame L, Lorenzoni V, Frenkel J, Gattorno M, Quartier P,, Martini A. An in Silico Health economic model applied to Cryopyrin Associated period syndromes (CAPS): cost effectiveness of prevention effects of ultra-orphan drugs for rare diseases. Value in Health 2015; 18(7): A669. 6. Cavallo, F., Trieste, L., Esposito, R., Aquilano, M., Dario, P., Turchetti, G. Are the elderly citizens ready for assisted living technologies? An Italian case Study. Value in Health 2015; 18(7): A514. 7. Trieste, L., Della Casa Alberighi O, Turchetti G, Pierotti F, Accame L, Lorenzoni V, Frenkel J, Gattorno M, Quartier P,, Martini A. Cost-effectiveness analysis and prevention effects of ultra-orphan drugs for rare diseases: an in silico model applied to Cryopyrin Associated Periodic Syndromes (CAPS). Pediatric Rheumatology 2015; 13(Suppl 1):P186. 8. Turchetti, G., Kroes, M., Lorenzoni, V., Trieste, L., Chapman, A., Wilson, G.,s Sweet, A.C, Neglia, D. The cost-effectiveness of diagnostic cardiac imaging for stable coronary artery disease. Expert Review of Pharmacoeconomics & Outcomes Research 2015; 31:1-9. 9. Trieste, L., Della Casa Alberighi O, Turchetti G, Pierotti F, Accame L, Lorenzoni V, Frenkel J, Gattorno M, Quartier P,, Martini A. Cost-effectiveness analysis and prevention effects of ultra-orphan drugs for rare diseases: an in silico model applied to Cryopyrin Associated Periodic Syndromes (CAPS). Poster accepted at ISSAID 2015: 8th International Congress of Familial Mediterranean Fever and Systemic Autoinflammatory Diseases. Pediatric Rheumatology 2015; 13(Suppl 1):P185. 10. Lorenzoni, V., Trieste, L., Turchetti, G. The cost effectiveness of drug therapies to treat secondary hyperparathyroidism in renal failure: a focus on evidence about paricalcitol and cinacalcet. Expert Review of Pharmacoeconomics & Outcomes Research 2015; 17:1-14. 11. Pierotti, F., Trieste, L., Turchetti, G. Different Strategies for Latent TB Assessment in Patients Undergoing Anti-TNF Treatment: an Economic Model. Value in Health, 2014; 17(7):, A551. 12. Gialetti, S., Trieste, L., Pierotti, F., Turchetti, G., Silvestri, M., Della Casa Alberighi, O. Comparison of Generic, Condition-Specific and Mapped Health State Utility Values for Pediatric Asthma. Value in Health 2014; 17(7): A552. 13. Turchetti, G., Vitiello N., Trieste L., Romiti, S., Geisler E., Micera, S. 2014. Why effectiveness of robot-mediated neuro-rehabilitation does not necessarily influence its adoption? IEEE Reviews in Biomedical Engineering 7: 143-153. 4 of 8 14. Trieste, L., Turchetti, G. 2014. Cost for TB care in developed countries: which data for an economic evaluation? Journal of Rheumatology 05/2014; 91:83-85. 15. Trieste, L., Palla, I., Fusco, F., Tani, C., Baldini, C., Mosca, M., Turchetti, G. 2012. The economic impact of gout: a systematic literature review. Clinical and Experimental Rheumatology 30: S145-148. 16. Trieste, L., Palla, I., Baldini, C., Talarico, R., D’Angiolella, L., Mosca, M., Turchetti, G. 2012. Systemic vasculitis: how little we know about their societal and economic burden. Clinical and Experimental Rheumatology 30: S154-156. 17. Palla, I., Trieste, L., Tani, C., Talarico, R., Cortesi, M., Mosca M., Turchetti, G. 2012. A systematic literature review of the economic impact of ankylosing spondylitis. Clinical and Experimental Rheumatology 30: S136-141. 18. Turchetti, G., Pierotti, F., Palla, I., Trieste, L. 2012. The definition of a new organizational, technology-based, integrated home care model. International Journal Of Computer Assisted Radiology And Surgery 7: S480: S481. Books Contributes in Volume Katiranta, A., Kulvik, M. Maijanen, S., Tahvanainen, A., Trieste, L., Turchetti, G., Tähitnen, M. 2015. Raiders of lost value. Helsinki: Taloustieto Oy. ISBN 978-951-628-632-0. 1. Belli, C., Trieste, L., Triulzi, I. 2016. La misurazione e la valutazione del fornitore/fornitura La Farmacologistica 2, Edizioni il Campano, forthcoming. 2. Turchetti, G., Trieste, L. 2014. Innovazione tecnologica, dinamica del contesto economico e logistica in sanità, in La Farmacologistica, Edizioni il Campano: Pisa. ISBN 978-8-67528-247-2. 3. Turchetti, G., Cannizzo, S. and Trieste, L. 2012 Natural and man-made disasters: challenges and international outlooks for insurance, in De Guttry, A., Gestri, M, and Venturini, G. (eds.), International Disaster Response Law, Asser TMC series, Springer Verlag. ISBN 978-90-6704-881-1. Conferences 1. Triulzi, I., Trieste, L., Belli, C., Pani, M. Turchetti, G. 2016. Development of an Objetive Feedback score for the evaluation of drug and medical device manufacturers/distributors as an additional parameter to be considered in public procurement. 21st Congress of the EAHP. Wien, 16-18th March 2016. 2. Trieste, L. China-Italy potential collaboration for research and consulting activities in economics and management of healthcare services. China - Italy Science, Technology & Innovation Week, Beijing (China), November 16-17, 2015. 3. Trieste, L. Organization and government of Healthcare systems: policy and managerial perspectives. China - Italy Science, Technology & Innovation Week, Chongqing (China), November 19, 2015. 4. Trieste, L. Economic evaluation of new biomedical technologies for a sustainable healthcare: market potential analysis, pharmaco-economics and HTA tools. China - Italy Science, Technology & Innovation Week, Chongqing (China), November 20, 2015. 5. Trieste, L., Della Casa Alberighi O, Turchetti G, Pierotti F, Accame L, Lorenzoni V, Frenkel J, Gattorno M, Quartier P,, Martini AAn in Silico Health economic model applied to Cryopyrin Associated period syndromes (CAPS): cost effectiveness of prevention effects of ultra-orphan drugs for rare diseases. ISPOR 18th Annual European Congress, Milan, 7-11 November 2015. 5 of 8 6. Cavallo, F., Trieste, L., Esposito, R., Aquilano, M., Dario, P., Turchetti, G. Are the elderly citizens ready for assisted living technologies? An Italian case Study. ISPOR 18th Annual European Congress, Milan, 7-11 November 2015. 7. Trieste, L., Della Casa Alberighi O, Turchetti G, Pierotti F, Accame L, Lorenzoni V, Frenkel J, Gattorno M, Quartier P,, Martini A. Cost-effectiveness analysis and prevention effects of ultra-orphan drugs for rare diseases: an in silico model applied to Cryopyrin Associated Periodic Syndromes (CAPS). Poster accepted at ISSAID 2015: 8th International Congress of Familial Mediterranean Fever and Systemic Autoinflammatory Diseases, 30 September - 3 October 2015, Dresden. 8. Della Casa Alberighi, Trieste, L., Accame L, Lorenzoni V, Pierotti F, Federici S, Gattorno M, Quartier P, Duong Ngoc P, Cabrera R, Martini A, Turchetti G. The RaDiCEA Project: Cost of illness (COI) analysis applied to Cryopyrin Associated Periodic Syndromes (CAPS). Poster accepted at ISSAID 2015: 8th International Congress of Familial Mediterranean Fever and Systemic Autoinflammatory Diseases. 30 September - 3 October 2015, Dresden. 9. Trieste, L. La valutazione economica della telemedicina. @ITIM2015, 15-th National Congress on Telemedicine and medical information, 10-12 September, Lamezia Terme (IT). 10. Trieste, L., Pagliai, T., Esposito, R., Cavallo, F., Dario, P., Turchetti, G. How to design a business model for technology-driven innovations like robots. The case of Robot-Era. 2015 R&D Management Conference. Pisa, 23-26 June 2015. 11. Trieste, L., Turchetti, G. Assessing the value of the use of diagnostic technology: trade offs for GPs. 2015 R&D Management Conference. Pisa, 23-26 June 2015. 12. Trieste, L. Il thesaurus EUROVOC come patrimonio informativo di base per le ontologie tematiche. OnLine Data Integration Network. WorkShop: CNR. Pisa, March 24, 2015. 13. Trieste, L., Turchetti, G., Della Casa Alberighi, O. Obiettivi e strategie per l’analisi farmacoeconomica nel Progetto RaDiCEA. Conference on Autoinflammatory Disorder, ISEF Gaslini, Genoa, 4 March 2015. 14. Gialetti, S., Trieste, L., Pierotti, F., Turchetti, G., Silvestri, M., Della Casa Alberighi, O. Comparison of Generic, Condition-Specific and Mapped Health State Utility Values for Pediatric Asthma. ISPOR 17th Annual European Congress, Amsterdam, 8-12 November 2014. 15. Pierotti, F. Trieste, L., Turchetti. G. Different Strategies for Latent TB assessment in patients undergoing anti-TNF treatment: An economic model. ISPOR 17th Annual European Congress, Amsterdam, 8-12 November. 16. Fusco, F., Trieste, L., Turchetti, G. 2013. Approaching 2014: Is Telemedicine Assessed from The Social Perspective? A Brief 2013 Systematic Review. Sixth International Conference on eHealth, Telemedicine, and Social Medicine, IARIA, 2014: 271-279. 17. Pierotti, F., Palla, I., Trieste, L., Turchetti, G. The definition of a new organizational, technology-based, integrated home care model. Poster presented at the 26th International CARS (computer assisted radiology and surgery) conference, Pisa, June 27-30, 2012. 18. Trieste, L., Turchetti, G. 2010. Liberalizzazioni, struttura di mercato e strategie di marketing: le tendenze nella distribuzione dei farmaci da banco. Italian Marketing Society, VII annual meeting, Ancona, September 2008. 6 of 8 Other contributes 1. Turchetti G., P. Gazzaniga, L. Trieste. 2012. Strumenti per favorire gli investimenti e la competitività delle imprese. Produzione, ricerca e innovazione nel settore dei dispositivi medici in Italia. Questioni aperte; 59-64. 2. Turchetti G., P. Gazzaniga, L. Trieste. 2012. Le start up. Produzione, ricerca e innovazione nel settore dei dispositivi medici in Italia. Rapporto; 33-36. 3. Turchetti G., P. Gazzaniga, L. Trieste. 2012. Finanziamenti pubblici. Produzione, ricerca e innovazione nel settore dei dispositivi medici in Italia. Questioni aperte; N. 1; 51-56. 4. L. Trieste. 2006. Farmaci e distribuzione: gli scenari futuri, Scuola Superiore Sant’Anna, Main Working Paper. Work in progress Books 1. Turchetti, G., Pierotti, F., Trieste, L., Lorenzoni, V. 2016. Introduction to the economic assessment in Healthcare. 2. Trieste, L., Lorenzoni, V., Turchetti, G. 2016. Methods and Models for the Cost-effectiveness Analysis in Healthcare 3. Trieste, L. 2015. L’evoluzione della distribuzione del farmaco e dell’erogazione dei servizi in farmacia. Un’analisi economica, storica, manageriale. Articles 1. Fusco F., Trieste, L., Turchetti. 2014. A Systematic Literature Review On CostEffectiveness In Telemedicine: The Hidden Path For Telelecare Diffusion. SSSA, IDM. 2. Turchetti, G., Cinquini, L., Trieste, L., Campanale, C., Tumino, E., Arena, A. 2013. Second step solutions for incomplete colonoscopy. Sensitivity, prevention, and cost saving of ENDOTICS, SSSA, IDM. 3. Trieste, L., Turchetti, G. 2013. Scarcity, Constant Returns and Resource Allocation in Health: the Inconsistencies of QALY as a measure of effectiveness. SSSA, IDM. 4. Trieste, L., Turchetti. 2013. G. The role of ultrasound in abdominal pain. Is it time to transfer the technology to GPs? A model for assessing the change. SSSA. MAIN Lab. 5. Fusco F., Trieste, L., Turchetti. 2013. G. Cost-effectiveness and diffusion of telemedicine: A systematic review on hinders and potential solution for Telemedicine adoption. SSSA. IDM. 6. Trieste, L., Turchetti, G. 2012. Using diagnostic technology: trade offs for GPs. SSSA, Main Lab. 7. Trieste, L., Turchetti, L. G. 2012. Models of learning, probability updating and the impact of diagnostic technology. SSSA, Main Lab. 8. Trieste, L., Turchetti, G, Geisler, E. 2013 The Columbus egg and the engineer effects in innovation adoption: when technology and problems do not fit. SSSA, IDM. 7 of 8 Editorial activities and reviewer Reviewer for: PharmacoEconomics, Applied Health Economics and Health Policy, Medical Research Archives, Journal of Rheumatology, Journal of Telemedicine and Telecare. Member of the Research Abstract Review Committee for the 2016 ISPOR 21st Annual International Meeting, Washington, DC, USA. Operative systems Hardware and Software Skills OX Mac, MSWindows Computer Programs MSOffice, LATEX, R, WinBugs, E-Views, STATA, SPSS, TreeAge, Neural Connection, Answer Tree, Protégé, NetLogo, OpenProj 8 of 8